Evidence map›Paper›PMID 31285322›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Nbn-Mre11 interaction is required for tumor suppression and genomic integrity.

Jun Hyun Kim, Alexander V Penson, Barry S Taylor, John H J Petrini

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. NBN Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and In Vitro DNA Damage Response Defects.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Article
  6. Article
  7. Article
  8. Breast Cancer Predisposition Genes and Synthetic Lethality.International journal of molecular sciences · 2021
    Review
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jun Hyun KimMolecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.ORCID 0000-0003-0196-8796
Alexander V PensonHuman Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
Barry S TaylorHuman Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065.
John H J PetriniMolecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065; petrinij@mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
MSKCC Pilot Center for Precision Disease ModelingU54OD020355 · OD · SLOAN-KETTERING INST CAN RESEARCH · PI LOWE, SCOTT W., SOLIT, DAVID B. · 2015 to 2019
$9.9M
Regulation of the DNA damage response by the Mre11 complexR37GM059413 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI PETRINI, JOHN HJ · 2012 to 2020
$5.2M
The Mre11 complex: linking recombination to checkpointsR01GM059413 · NIGMS · UNIVERSITY OF WISCONSIN MADISON · PI PETRINI, JOHN HJ · 1999 to 2011
$5.2M
Understanding Long Tail Driver Mutations in CancerR01CA204749 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SCHULTZ, NIKOLAUS · 2017 to 2021
$2.0M
Targeting AKT-Mutant Human CancersR01CA207244 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SOLIT, DAVID B. · 2016 to 2020
$2.0M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA204749NCI NIH HHS R01 CA207244NIGMS NIH HHS R01 GM059413NIGMS NIH HHS R37 GM059413NIH HHS U54 OD020355
6 · The paper itself

Abstract

We derived a mouse model in which a mutant form of Nbn/Nbs1

Indexed as

Gene Expression Regulation, LeukemicAcid Anhydride HydrolasesAnimalsB-LymphocytesBone MarrowCell Cycle ProteinsCheckpoint Kinase 1Disease Models, AnimalDNA-Binding ProteinsGenomic InstabilityHematopoiesisHumansIkaros Transcription FactorMiceMice, KnockoutMRE11 Homologue ProteinAcid Anhydride HydrolasesBcl6 protein, mouseBcor protein, mouseCell Cycle ProteinsCheckpoint Kinase 1Chek1 protein, mouseDNA-Binding ProteinsIkaros Transcription FactorMre11a protein, mouseMRE11 Homologue ProteinNijmegen breakage syndrome 1 protein, mouseNotch1 protein, mouseProto-Oncogene Proteins c-bcl-6Rad50 protein, mouseReceptor, Notch1Repressor ProteinsTrp53 protein, mouseTumor Suppressor Protein p53Zfpn1a1 protein, mouseDNA damage responsegenomic instabilityNbn−Mre11 interactiontumor suppression

Identifiers

PMID31285322
PMCPMC6660787
OpenAlexW2961219990

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.